PortfoliosLab logoPortfoliosLab logo
NVS vs. ICE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NVS vs. ICE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novartis AG (NVS) and Intercontinental Exchange, Inc. (ICE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NVS achieves a 14.40% return, which is significantly higher than ICE's -12.95% return. Over the past 10 years, NVS has underperformed ICE with an annualized return of 11.14%, while ICE has yielded a comparatively higher 11.91% annualized return.


NVS

1D
-0.55%
1M
2.22%
YTD
14.40%
6M
18.98%
1Y
30.60%
3Y*
19.57%
5Y*
14.77%
10Y*
11.14%

ICE

1D
1.12%
1M
-9.22%
YTD
-12.95%
6M
-13.36%
1Y
-20.60%
3Y*
10.22%
5Y*
5.87%
10Y*
11.91%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NVS vs. ICE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NVS
Novartis AG
14.40%46.95%0.02%16.14%8.06%-3.65%3.34%13.92%5.95%19.42%
ICE
Intercontinental Exchange, Inc.
-12.95%9.92%17.46%27.12%-23.91%19.94%26.15%24.47%8.11%26.60%

Correlation

The correlation between NVS and ICE is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.30

Correlation (10Y)
Calculated over the trailing 10-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Nov 16, 2005

0.29

The correlation between NVS and ICE shifts across timeframes, from 0.19 (1 year) to 0.30 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NVS:

$293.28B

ICE:

$80.10B

EPS

NVS:

$6.99

ICE:

$6.85

PE Ratio

NVS:

21.90

ICE:

20.53

PEG Ratio

NVS:

1.48

ICE:

2.48

PS Ratio

NVS:

5.29

ICE:

6.15

PB Ratio

NVS:

7.62

ICE:

2.71

Total Revenue (TTM)

NVS:

$56.05B

ICE:

$13.08B

Gross Profit (TTM)

NVS:

$42.19B

ICE:

$8.93B

EBITDA (TTM)

NVS:

$22.40B

ICE:

$7.05B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NVS vs. ICE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVS
NVS Risk / Return Rank: 8080
Overall Rank
NVS Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
NVS Sortino Ratio Rank: 7979
Sortino Ratio Rank
NVS Omega Ratio Rank: 7777
Omega Ratio Rank
NVS Calmar Ratio Rank: 8080
Calmar Ratio Rank
NVS Martin Ratio Rank: 8080
Martin Ratio Rank

ICE
ICE Risk / Return Rank: 99
Overall Rank
ICE Sharpe Ratio Rank: 66
Sharpe Ratio Rank
ICE Sortino Ratio Rank: 1010
Sortino Ratio Rank
ICE Omega Ratio Rank: 1010
Omega Ratio Rank
ICE Calmar Ratio Rank: 1212
Calmar Ratio Rank
ICE Martin Ratio Rank: 66
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVS vs. ICE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and Intercontinental Exchange, Inc. (ICE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NVSICEDifference
Sharpe ratioReturn per unit of total volatility

+2.42

Sortino ratioReturn per unit of downside risk

+3.31

Omega ratioGain probability vs. loss probability

1.26

0.85

+0.41

Calmar ratioReturn relative to maximum drawdown

2.43

-0.80

+3.23

Martin ratioReturn relative to average drawdown

5.88

-1.50

+7.38

NVS vs. ICE - Sharpe Ratio Comparison

The current NVS Sharpe Ratio is 1.47, which is higher than the ICE Sharpe Ratio of -0.95. The chart below compares the historical Sharpe Ratios of NVS and ICE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NVS vs. ICE - Drawdown Comparison

The maximum NVS drawdown since its inception was -42.10%, smaller than the maximum ICE drawdown of -73.94%. Use the drawdown chart below to compare losses from any high point for NVS and ICE.


Loading charts...

Drawdown Indicators


NVSICEDifference

Max Drawdown

Largest peak-to-trough decline

-42.10%

-73.94%

+31.84%

Max Drawdown (1Y)

Largest decline over 1 year

-12.65%

-25.87%

+13.22%

Max Drawdown (3Y)

Largest decline over 3 years

-19.95%

-25.87%

+5.92%

Max Drawdown (5Y)

Largest decline over 5 years

-20.42%

-34.32%

+13.90%

Max Drawdown (10Y)

Largest decline over 10 years

-26.03%

-34.32%

+8.29%

Current Drawdown

Current decline from peak

-6.46%

-24.75%

+18.29%

Average Drawdown

Average peak-to-trough decline

-10.92%

-16.46%

+5.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.23%

13.74%

-8.51%

Volatility

NVS vs. ICE - Volatility Comparison

Novartis AG (NVS) has a higher volatility of 7.18% compared to Intercontinental Exchange, Inc. (ICE) at 6.26%. This indicates that NVS's price experiences larger fluctuations and is considered to be riskier than ICE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NVSICEDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.18%

6.26%

+0.92%

Volatility (6M)

Calculated over the trailing 6-month period

14.96%

18.52%

-3.56%

Volatility (1Y)

Calculated over the trailing 1-year period

21.02%

21.86%

-0.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.89%

21.07%

-2.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.64%

22.20%

-2.56%

Dividends

NVS vs. ICE - Dividend Comparison

NVS's dividend yield for the trailing twelve months is around 3.12%, more than ICE's 1.39% yield.


PositionTTM20252024202320222021202020192018201720162015
ICE
Intercontinental Exchange, Inc.
1.39%1.19%1.21%1.31%1.48%0.97%1.04%1.19%1.27%1.13%1.21%1.13%
NVS
Novartis AG
3.12%2.90%3.84%3.44%3.70%3.86%3.22%3.03%3.47%3.24%3.73%3.10%

Financials

NVS vs. ICE - Financials Comparison

This section allows you to compare key financial metrics between Novartis AG and Intercontinental Exchange, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B12.00B14.00B20222023202420252026
13.52B
3.67B
(NVS) Total Revenue
(ICE) Total Revenue
Values in USD except per share items

NVS vs. ICE - Profitability Comparison

The chart below illustrates the profitability comparison between Novartis AG and Intercontinental Exchange, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

55.0%60.0%65.0%70.0%75.0%80.0%20222023202420252026
74.4%
78.8%
Portfolio components
NVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a gross profit of 10.07B and revenue of 13.52B. Therefore, the gross margin over that period was 74.4%.

ICE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Intercontinental Exchange, Inc. reported a gross profit of 2.89B and revenue of 3.67B. Therefore, the gross margin over that period was 78.8%.

NVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported an operating income of 4.24B and revenue of 13.52B, resulting in an operating margin of 31.3%.

ICE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Intercontinental Exchange, Inc. reported an operating income of 1.67B and revenue of 3.67B, resulting in an operating margin of 45.4%.

NVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a net income of 3.16B and revenue of 13.52B, resulting in a net margin of 23.3%.

ICE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Intercontinental Exchange, Inc. reported a net income of 1.41B and revenue of 3.67B, resulting in a net margin of 38.5%.


Frequently Asked Questions


NVS and ICE have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NVS has higher volatility (7.18%) compared to ICE (6.26%). In terms of maximum drawdown, NVS dropped -42.10% vs ICE's -73.94%.

NVS currently has the higher Sharpe Ratio (1.47 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NVS and ICE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer